Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-16 Sale | 2024-12-17 6:10 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 165 | $0.3523 | $58 | 22,563 (Direct) | View |
| 2024-12-16 Sale | 2024-12-17 6:08 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 3,117 | $0.36294 | $1,131 | 7,791,655 (Indirect Direct) | View |
| 2024-12-16 Sale | 2024-12-17 6:06 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 577 | $0.35871 | $207 | 28,602 (Direct) | View |
| 2024-12-16 Sale | 2024-12-17 6:04 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 430 | $0.35587 | $153 | 32,093 (Direct) | View |
| 2024-12-16 Sale | 2024-12-17 6:03 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 430 | $0.35306 | $152 | 36,601 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:55 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 6,272 | $0.55 | $3,450 | 19,011 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:55 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 6,863 | $0.55 | $3,775 | 23,770 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:54 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 7,175 | $0.55 | $3,946 | 28,278 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:54 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 7,175 | $0.55 | $3,946 | 20,279 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:53 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 5,556 | $0.55 | $3,056 | 19,601 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:23 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 355 | $0.6893 | $245 | 22,955 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:21 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 1,982 | $0.68966 | $1,367 | 7,789,824 (Indirect Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:21 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 356 | $0.6899 | $246 | 14,956 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:20 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 345 | $0.69 | $238 | 17,885 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:19 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 138 | $0.6908 | $95 | 7,034 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:18 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 215 | $0.6908 | $149 | 11,533 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:27 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 372 | $1.28 | $476 | 23,310 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:26 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 244 | $1.2627 | $308 | 11,748 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:26 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 372 | $1.2622 | $470 | 15,312 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:25 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 361 | $1.2632 | $456 | 18,230 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:25 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 155 | $1.285 | $199 | 7,172 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:24 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 2,134 | $1.2835 | $2,739 | 7,791,806 (Indirect Direct) | View |
| 2024-06-04 Sale | 2024-06-06 8:35 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal BioXcel Holdings Inc. BioXcel LLC CEO and President 10% Owner | 1,427,494 | $0.28381 | $405,135 | 7,731,185 (Indirect Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 165 | $2.6211 | $432 | 16,327 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 5,268 | $2.624 | $13,823 | 8,655,189 (Indirect Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,069 | $2.635 | $2,817 | 15,684 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:31 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 1,008 | $2.6351 | $2,656 | 11,992 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:30 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 1,012 | $2.6358 | $2,667 | 18,591 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:30 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 1,067 | $2.635 | $2,812 | 23,682 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-14 Exercise | 2024-12-17 6:10 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 521 | $0 | 22,563 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:08 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 6,110 | $0 | 7,791,655 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:06 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,083 | $0 | 28,602 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:04 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 1,083 | $0 | 32,093 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:03 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 1,083 | $0 | 36,601 (Direct) | View |
| 2024-11-30 Exercise(A) | 2024-12-04 4:05 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 27,089 | $0 | 325,077 (Direct) | View |
| 2024-11-30 Exercise | 2024-12-03 4:05 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 27,089 | $0 | 325,087 (Direct) | View |
| 2024-11-21 Option Award | 2024-12-03 4:05 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 297,988 | $0 | 325,087 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:06 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 325,077 | $0 | 325,077 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 21,250 | $0 | 19,011 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 21,250 | $0 | 23,770 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:54 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 21,250 | $0 | 28,278 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:54 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 21,250 | $0 | 20,279 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:53 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 21,250 | $0 | 19,601 (Direct) | View |
| 2024-09-14 Exercise | 2024-09-17 7:23 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 1,084 | $0 | 22,955 (Direct) | View |
| 2024-09-14 Exercise | 2024-09-17 7:21 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 6,109 | $0 | 7,789,824 (Direct) | View |
| 2024-09-14 Exercise | 2024-09-17 7:21 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,084 | $0 | 14,956 (Direct) | View |
| 2024-09-14 Exercise | 2024-09-17 7:20 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 1,084 | $0 | 17,885 (Direct) | View |
| 2024-09-14 Exercise | 2024-09-17 7:19 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 521 | $0 | 7,034 (Direct) | View |
| 2024-09-15 Exercise | 2024-09-17 7:18 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 11,533 (Direct) | View |
| 2024-06-15 Exercise(A) | 2024-09-17 7:17 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 8,250 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:27 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 1,083 | $0 | 23,310 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-18 9:26 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 11,748 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:26 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,083 | $0 | 15,312 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:25 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 1,083 | $0 | 18,230 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:25 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 521 | $0 | 7,172 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:24 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 6,109 | $0 | 7,791,806 (Direct) | View |
| 2024-06-10 Other | 2024-06-11 7:02 pm | N/A 2034-06-10 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-11 7:02 pm | N/A 2034-06-10 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-11 7:01 pm | N/A 2034-06-10 | BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-11 7:01 pm | N/A 2034-06-10 | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-11 7:00 pm | N/A 2034-06-10 | BioXcel Therapeutics Inc. | BTAI | MILLER MICHAEL PATRICK Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-11 7:00 pm | N/A 2034-06-10 | BioXcel Therapeutics Inc. | BTAI | Bray June Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 2,771 | $0 | 16,327 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 16,610 | $0 | 8,655,189 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,771 | $0 | 15,684 (Direct) | View |
| 2024-03-15 Exercise | 2024-04-08 7:31 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 3,000 | $0 | 11,992 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:30 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 2,771 | $0 | 18,591 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:30 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 2,771 | $0 | 23,682 (Direct) | View |